|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: OCULAR SCIENCES INC /DE/, 10-Q, EX-10.03, 2000-08-14 |
Next: OCULAR SCIENCES INC /DE/, 10-Q, EX-27.01, 2000-08-14 |
<PAGE> 1
Exhibit 11.01
OCULAR SCIENCES, INC.
STATEMENT REGARDING COMPUTATION OF NET INCOME PER SHARE (BASIC AND DILUTED)
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
2000 1999 2000 1999
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Net income per share (basic):
Net income $17,477,000 $ 9,314,000 $24,610,000 $15,969,000
=========== =========== =========== ===========
Weighted average common shares outstanding 23,112,094 22,809,644 23,058,837 22,718,704
=========== =========== =========== ===========
Net income per share (basic) $ 0.76 $ 0.41 $ 1.07 $ 0.70
=========== =========== =========== ===========
Net income per share (diluted):
Net income (diluted): $17,477,000 $ 9,314,000 $24,610,000 $15,969,000
=========== =========== =========== ===========
Weighted average common shares outstanding 23,112,094 22,809,644 23,058,837 22,718,704
Weighted average shares of stock options
under the treasury stock method 213,537 680,141 265,851 684,333
----------- ----------- ----------- -----------
Weighted average common and dilutive
potential common shares outstanding 23,325,631 23,489,785 23,324,688 23,403,037
=========== =========== =========== ===========
Net income per share (diluted) $ 0.75 $ 0.40 $ 1.06 $ 0.68
=========== =========== =========== ===========
</TABLE>
|
|